Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
binimetinib (mektovi) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
carboplatin (paraplatin) (1 trial)
palbociclib (ibrance) (1 trial)
pembrolizumab (keytruda) (1 trial)
atezolizumab (Tecentriq) (2 trials)
bacille calmette-guerin (1 trial)
lurbinectedin (Zepzelca) (1 trial)
Breast Neoplasms (Phase 2)
Carcinoma, Small Cell (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (8 total)